Third Wave Announces Launch of Universal Invader® Program
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Third Wave Technologies, Inc.
502 S. Rosa Rd.
Madison, WI, 53719
Press release date: November 16, 2006
ORLANDO, Fla., Nov. 16 -- Third Wave Technologies Inc. (NASDAQ:TWTI) today announced the launch of its Universal Invader® Program, which allows customers to design, build and optimize their own Invader® chemistry-based assays.
"Third Wave is pleased to open access to our Invader® chemistry, making an already simple, flexible chemistry even easier for customers to use," said Kevin T. Conroy, president and chief executive of Third Wave. "The Universal Invader® Program enables Third Wave to better serve our customers by providing them the flexibility to develop tests that meet their specific needs and interests, outside of our standard menu of products."
The program includes web-based Universal Invader® design software. The software generates the designs for all oligonucleotides, or DNA probes, needed for customers to build Invader® chemistry-based reactions for their specific DNA targets of interest in their own laboratories. Participants in the Universal Invader® Program can purchase their design-specific oligonucleotides from a third-party vendor and general purpose reagents, including Third Wave's Cleavase® enzyme, directly from the company.
The program utilizes the Third Wave's Invader Plus® chemistry, which combines the accuracy and specificity of its Invader® chemistry with the sensitivity of PCR sample amplification. Customers can use the Invader Plus® chemistry without paying any royalty because the relevant PCR patents expired last year. For more information about the Universal Invader® Program, please visit http://www.universalinvader.com/.
About Third Wave Technologies
Third Wave develops and markets molecular diagnostic reagents for a variety of DNA and RNA analysis applications to meet the needs of our customers. The company offers a number of products based on its Invader® chemistry for clinical testing. Third Wave offers in vitro diagnostic kits, and analyte specific, general purpose, and research use only reagents for nucleic acid analysis. For more information about Third Wave and its products, please visit the company's website at http://www.twt.com/.
Contact: Rod Hise Third Wave Technologies 608 663-4010
Source: Third Wave Technologies Inc.
Web site: http://www.twt.com/ http://www.universalinvader.com/